Trial record 1 of 1 for:    hepatocellular carcinoma sorafenib mFOLFOX
Previous Study | Return to List | Next Study

Sorafenib + mFOLFOX for Hepatocellular Carcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Massachusetts General Hospital
Sponsor:
Information provided by (Responsible Party):
Andrew X. Zhu, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01775501
First received: January 18, 2013
Last updated: March 13, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)